87 related articles for article (PubMed ID: 9007154)
21. [Anemia in cancer patients before treatment].
Auclerc G; Meric JB; Pommeyrol A; Rixe O; Khayat D
Bull Cancer; 2003 Apr; 90 Spec No():S128-32. PubMed ID: 12856424
[TBL] [Abstract][Full Text] [Related]
22. Weekly administration of epoetin beta for chemotherapy-induced anemia in cancer patients: results of a multicenter, Phase III, randomized, double-blind, placebo-controlled study.
Tsuboi M; Ezaki K; Tobinai K; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2009 Mar; 39(3):163-8. PubMed ID: 19164318
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
24. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
Li H; Wang SX
Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
[TBL] [Abstract][Full Text] [Related]
25. Adding growth factors or interleukin-3 to erythropoietin has limited effects on anemia of transfusion-dependent patients with myelodysplastic syndromes unresponsive to erythropoietin alone.
Musto P; Sanpaolo G; D'Arena G; Scalzulli PR; Matera R; Falcone A; Bodenizza C; Perla G; Carotenuto M
Haematologica; 2001 Jan; 86(1):44-51. PubMed ID: 11146570
[TBL] [Abstract][Full Text] [Related]
26. [Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].
Queipo Zaragozá JA; Chicote Pérez F; Beltrán Meseguer JF; Borrell Palanca A; Giner Marco V; Esteve Claramunt J; Pastor Sempere F
Arch Esp Urol; 2004; 57(1):35-40. PubMed ID: 15112869
[TBL] [Abstract][Full Text] [Related]
27. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
28. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
29. Prior red blood cell transfusions in cancer patients increase the risk of subsequent transfusions with or without recombinant human erythropoietin management.
Couture F; Turner AR; Melosky B; Xiu L; Plante RK; Lau CY; Quirt I
Oncologist; 2005 Jan; 10(1):63-71. PubMed ID: 15632253
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
Hasselbalch HC; Clausen NT; Jensen BA
Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
[TBL] [Abstract][Full Text] [Related]
31. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
León Molinari P; Jiménez Monteagudo M; Barona Zamora P; Riol Diego M; Castro Paz L; Sierrasesúmaga Ariznavarreta L
An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
[TBL] [Abstract][Full Text] [Related]
32. [Use of human recombinant erythropoietin in children with cancer].
Guyot D; Margueritte G
Arch Pediatr; 2005 Sep; 12(9):1376-82. PubMed ID: 16084072
[TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment.
Corapcioglu F; Aksu G; Basar EZ; Demirel A; Oncel S; Mutlu A
Pediatr Hematol Oncol; 2008 Sep; 25(6):509-21. PubMed ID: 18728970
[TBL] [Abstract][Full Text] [Related]
34. Effects of cancer-related anemia on clinical and quality-of-life outcomes.
Gillespie TW
Clin J Oncol Nurs; 2002; 6(4):206-11. PubMed ID: 12087616
[TBL] [Abstract][Full Text] [Related]
35. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Chawla B; Iqbal FM; Chawla MS
Compr Ther; 2009; 35(3-4):199-203. PubMed ID: 20043618
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO].
Dyjas R; Wiecek A; Kokot F
Przegl Lek; 1996; 53(6):486-90. PubMed ID: 8927751
[TBL] [Abstract][Full Text] [Related]
37. Effect of transfusion regime on erythropoietin levels in refractory hypoplastic anemia.
Napier JA; Evans J
Vox Sang; 1980 Nov; 39(5):246-9. PubMed ID: 7257233
[TBL] [Abstract][Full Text] [Related]
38. The significance of perioperative anemia in patients with resectable gastrointestinal tract tumors.
Griniatsos J; Papaconstantinou I; Felekouras E; Michail PO; Bakoyiannis C; Bramis J
J BUON; 2004; 9(3):247-53. PubMed ID: 17415822
[TBL] [Abstract][Full Text] [Related]
39. [Recombinant human erythropoietin (r-Hu-EPO) in the treatment of nephrogenic anemia].
Hanicki Z
Pol Arch Med Wewn; 1988 Nov; 80(5):290-3. PubMed ID: 3271331
[No Abstract] [Full Text] [Related]
40. [Transfusion therapy in aplastic anemia].
Danieli G
G Clin Med; 1974 Jun; 55(6):390-400. PubMed ID: 4465151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
